US.CAH · Cardinal Health

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.1280794476174236,
        "turnoverUsdM": 389.58205222000004,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.CAH",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 224.6342,
      "strength_details": {
        "ma_score": 2,
        "atr_score": 2,
        "rsi_score": 1,
        "macd_score": 1.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.2,
      "stop_loss_percent": 4.3,
      "take_profit_price": 246.351,
      "target_multiplier": 1.6,
      "technical_strength": 1.48,
      "take_profit_percent": 5
    },
    "positionPoints": 1.6,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 4.256158895234847,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 63.7,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 58.7,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 5
  },
  "market": {
    "ma20": 235.065,
    "ma50": 233.0008,
    "close": 234.62,
    "prevClose": 234.55,
    "avgVolume20": 1847969,
    "volumeRatio": 0.9,
    "changePercent": 0.03
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 5,
    "details": {
      "ret_5d": 0.00968283341223053,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 5,
      "vcp_bonus": 0,
      "vol_ratio": 0.8881168551585444,
      "ret_points": 4,
      "vol_points": 0,
      "range_ratio": 0.5737420009587734,
      "volat_points": 0,
      "day_range_pct": 0.014704714005626219,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 63.7,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 60,
        "contribution": 3
      },
      {
        "raw": 7.6,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 38,
        "contribution": 7.6
      },
      {
        "raw": 9.8,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 65.33,
        "contribution": 9.8
      },
      {
        "raw": 6,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 30,
        "contribution": 6
      },
      {
        "raw": 7.4,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 74,
        "contribution": 7.4
      },
      {
        "raw": 18.9,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 63,
        "contribution": 18.9
      },
      {
        "raw": 6,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 60,
        "contribution": 6
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 58.7,
    "details": [
      "基本面分析總分: 3/5分",
      "資金流分析總分: 7.6/20分",
      "市場環境分析總分: 9.8/15分",
      "催化劑分析: 6/20分",
      "風險管理總分: 7.4/10分",
      "技術信號分析總分: 18.9/30分",
      "情緒分析: 6/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 6,
      "基本面": 3,
      "資金流": 7.6,
      "市場環境": 9.8,
      "情緒分析": 6,
      "技術信號": 18.9,
      "風險管理": 7.4
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 1
            }
          },
          "catalystPoints": 6
        }
      },
      "基本面": {
        "max": 5,
        "grade": "一般",
        "items": {
          "pbPoints": 0,
          "pePoints": 0.2,
          "epsPoints": 0.4,
          "roePoints": 0,
          "debtPoints": 0.5,
          "marginPoints": 0,
          "turnoverUsdM": 389.58205222000004,
          "volumePoints": 0.5,
          "revenuePoints": 0.6,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 1.6,
          "obvPoints": 2.4,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.CAH",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "一般",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 14.43
            }
          },
          "trend": {
            "score": 2.8,
            "details": {
              "qqq": {
                "ma20": 718.7765020000002,
                "ma50": 711.5868006399995,
                "name": "QQQ",
                "close": 716.76001,
                "points": 1.4
              },
              "spy": {
                "ma20": 769.6849949,
                "ma50": 754.36140122,
                "name": "SPY",
                "close": 767.049988,
                "points": 1.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.1280794476174236,
          "atrPoints": 3,
          "cciPoints": 1.6,
          "vixPoints": 2.4,
          "marketTrendPoints": 2.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "一般",
        "items": {
          "sentiment": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 5,
              "sentimentScoreRaw": 1.5
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141281569,
                "url": "https://finnhub.io/api/news?id=332992374de53bd9f6bad766edce936b1b27e4f99ea6a4c70d3e55ef4f8bc6e0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health earnings and capital return in focus Cardinal Health (CAH) has drawn fresh attention after releasing its fourth quarter and full year 2026 results, paired with a new US$5b share repurchase authorization and a confirmed quarterly dividend. The latest numbers give you an updated view of how the healthcare distributor is converting its large revenue base into profit and cash flow. They also show how management is choosing to return capital to shareholders through buybacks and...",
                "category": "company",
                "datetime": 1787191883,
                "headline": "What Is Drawing Attention To Cardinal Health (CAH) Today?"
              },
              {
                "id": 141257357,
                "url": "https://finnhub.io/api/news?id=bb7bbbae3a015fc8491aace84d7c755899956d9398b88bd5dfe4dbd9e355f6f1",
                "image": "",
                "source": "Fintel",
                "related": "CAH",
                "summary": "",
                "category": "company",
                "datetime": 1787177498,
                "headline": "RBC Capital Initiates Coverage of Cardinal Health (CAH) with Outperform Recommendation"
              },
              {
                "id": 141281562,
                "url": "https://finnhub.io/api/news?id=9bec7570f1e53c9fc78fbb7e90d04b77446549aa9fbb3b3787dc5c736db5d10e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "On August 11, Cardinal Health (NYSE:CAH) reported fourth-quarter fiscal 2026 results that on the surface look almost too good to be true. Non-GAAP diluted EPS jumped 40% year over year to $2.91, and full-year adjusted free cash flow hit $5 billion. But a large piece of that quarterly jump came from a one-time tariff refund, […]",
                "category": "company",
                "datetime": 1787161820,
                "headline": "Cardinal Health’s (CAH) Big Earnings Beat Hides a More Complicated Story"
              },
              {
                "id": 141281564,
                "url": "https://finnhub.io/api/news?id=f6f0cb7498e1d33d53716ba1b2fe269651b58bc632951f6ab547d308849691eb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "GLP-1 tailwinds and specialty strength drove pharma profit up 21% in Q4.",
                "category": "company",
                "datetime": 1787067813,
                "headline": "Cardinal Health (CAH) Q4 2026 Earnings Call Transcript"
              },
              {
                "id": 141281572,
                "url": "https://finnhub.io/api/news?id=9cc59241381a967f196ccd02f616c9c312113bf0d32eb77878540773004d7acd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.",
                "category": "company",
                "datetime": 1786988703,
                "headline": "3 Reasons Growth Investors Will Love Cardinal (CAH)"
              },
              {
                "id": 141237775,
                "url": "https://finnhub.io/api/news?id=a4bceb6094e64669174ffe675842af9d12ccc8f13e47a1a88b434206e3cc4192",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Healthcare distributor and services company Cardinal Health (NYSE:CAH) fell short of the market’s revenue expectations in Q2 CY2026, but sales rose 5.8% year on year to $63.67 billion. Its non-GAAP profit of $2.60 per share was 7.4% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1786718220,
                "headline": "CAH Q2 CY2026 Deep Dive: Specialty Momentum, Strategic Investments, and Guidance Above Street Expectations"
              },
              {
                "id": 141212244,
                "url": "https://finnhub.io/api/news?id=a9b9bac25f326babf2cf9fff8b8b91c7e59caef31b954bb8195e667417086299",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (CAH) gave investors plenty to like in its fiscal fourth-quarter report this week, sending shares to a record high of $258 as Wall Street digests another earnings beat and an encouraging FY27 outlook.",
                "category": "company",
                "datetime": 1786659000,
                "headline": "Cardinal Health Stock Hits a Record High After Earnings: Is CAH Still a Buy?"
              },
              {
                "id": 141202025,
                "url": "https://finnhub.io/api/news?id=22eea6402014929c0f36f13688e8fe800f6307f7d21c4ce3ebb25dde2198951f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "After a very strong multi year run, Cardinal Health stock is now being judged by a low overall value score and fresh questions about risk controls, so investors are weighing whether the current price still fairly reflects its fundamentals. Cardinal Health has delivered about 409.2% over the past 5 years, which sets expectations high for what comes next. The recent levothyroxine tablet recalls and the appointment of a new Chief Accounting Officer may affect how the market prices Cardinal...",
                "category": "company",
                "datetime": 1786561927,
                "headline": "Cardinal Health (CAH) Stock Looks About Right On Earnings But Stretched On Broader Checks"
              }
            ],
            "raw_source": [
              {
                "id": 141302889,
                "url": "https://finnhub.io/api/news?id=416bab4b1c0101a3af5b6372944a639d163e1a4ca056c79bfe84910c7f68b6e0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Mary C. Scherer reduced her direct equity but retains 2,811 shares after the stock delivered a 58% return over the past year.",
                "category": "company",
                "datetime": 1787489912,
                "headline": "What to Know About the Latest Sale From Cardinal Health's Chief Accounting Officer"
              },
              {
                "id": 141302890,
                "url": "https://finnhub.io/api/news?id=ff6c5bc5e1602794a100e7f9ac2028e3ce773d8e891979bf3aa2f2b45090397a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Alt divested part of his direct equity stake after the stock surged 57% over the past year, retaining 20,495 shares worth $4.82 million.",
                "category": "company",
                "datetime": 1787489479,
                "headline": "Cardinal Health's CFO Moved $9.9 Million of Stock. Here's What Long-Term Investors Should Know"
              },
              {
                "id": 141302891,
                "url": "https://finnhub.io/api/news?id=97960969121b0a2e7900f606decbb1c933ac1e1698d04ddb351595c45c228b7a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "This insider sale cut an equity stake following a strong 57% one-year stock run, leaving $4.2 million in direct holdings.",
                "category": "company",
                "datetime": 1787488920,
                "headline": "Cardinal Health's Medical Segment Boss Sold $8 Million in Stock. Here's What to Know"
              },
              {
                "id": 141302893,
                "url": "https://finnhub.io/api/news?id=b68995767b73314e066ba16ebd0a5e5a40067120b091ad131376f9d7621e8b56",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Weitzman's equity reduction follows a 57% one-year stock price surge, leaving her with $18.3 million in direct holdings.",
                "category": "company",
                "datetime": 1787488459,
                "headline": "Cardinal Health's Pharma Chief Sold 7,354 Shares and Still Grew Her Stake by 47%. Here's How That Happened"
              },
              {
                "id": 141302894,
                "url": "https://finnhub.io/api/news?id=74d086da412e2f40effa473609db11e342a4c02990853c02087d42b7ab2afb5c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Michelle Greene reduced her direct equity stake following strong stock appreciation, retaining 10,330 shares worth $2.43 million.",
                "category": "company",
                "datetime": 1787488071,
                "headline": "The CIO of Cardinal Health Parted With 11,650 Shares. Here's Whether It Matters for Long-Term Investors"
              },
              {
                "id": 141302895,
                "url": "https://finnhub.io/api/news?id=b3c419f800f6985e46c2edeccfe50c3194e81705fe3b88954694b93594b8c862",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Jessica Mayer holds 33,076 shares valued at $7.77 million.",
                "category": "company",
                "datetime": 1787487298,
                "headline": "Cardinal Health's Legal Chief Just Filed an Insider Transaction. Here's What to Know"
              },
              {
                "id": 141302896,
                "url": "https://finnhub.io/api/news?id=886093364dc83c06f6d58fa489627171dda909f2ce2ded5a91ad90ae33d05b8c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Hollar divested 125,000 shares across two trading sessions, reducing his direct holdings following a 58% one-year stock surge.",
                "category": "company",
                "datetime": 1787485488,
                "headline": "Cardinal Health's CEO Moved 124,529 Shares in Two Days. Here's What Long-Term Investors Should Know"
              },
              {
                "id": 141281561,
                "url": "https://finnhub.io/api/news?id=7a9934a73093f4678229a178aa7bb825d5e23cc05353b69220c25cff9f855440",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CEO Jason Hollar leads a wave of insider selling that saw top executives liquidate nearly $60 million worth of company stock.",
                "category": "company",
                "datetime": 1787359440,
                "headline": "Cardinal Health CEO Sells $29 Million in Stock After Earnings Send Shares to Record"
              },
              {
                "id": 141281569,
                "url": "https://finnhub.io/api/news?id=332992374de53bd9f6bad766edce936b1b27e4f99ea6a4c70d3e55ef4f8bc6e0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health earnings and capital return in focus Cardinal Health (CAH) has drawn fresh attention after releasing its fourth quarter and full year 2026 results, paired with a new US$5b share repurchase authorization and a confirmed quarterly dividend. The latest numbers give you an updated view of how the healthcare distributor is converting its large revenue base into profit and cash flow. They also show how management is choosing to return capital to shareholders through buybacks and...",
                "category": "company",
                "datetime": 1787191883,
                "headline": "What Is Drawing Attention To Cardinal Health (CAH) Today?"
              },
              {
                "id": 141257357,
                "url": "https://finnhub.io/api/news?id=bb7bbbae3a015fc8491aace84d7c755899956d9398b88bd5dfe4dbd9e355f6f1",
                "image": "",
                "source": "Fintel",
                "related": "CAH",
                "summary": "",
                "category": "company",
                "datetime": 1787177498,
                "headline": "RBC Capital Initiates Coverage of Cardinal Health (CAH) with Outperform Recommendation"
              },
              {
                "id": 141281562,
                "url": "https://finnhub.io/api/news?id=9bec7570f1e53c9fc78fbb7e90d04b77446549aa9fbb3b3787dc5c736db5d10e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "On August 11, Cardinal Health (NYSE:CAH) reported fourth-quarter fiscal 2026 results that on the surface look almost too good to be true. Non-GAAP diluted EPS jumped 40% year over year to $2.91, and full-year adjusted free cash flow hit $5 billion. But a large piece of that quarterly jump came from a one-time tariff refund, […]",
                "category": "company",
                "datetime": 1787161820,
                "headline": "Cardinal Health’s (CAH) Big Earnings Beat Hides a More Complicated Story"
              },
              {
                "id": 141281563,
                "url": "https://finnhub.io/api/news?id=f198ed3b0fb67fa0c414360083a0eb1dddb2ec041ab74231173ee46546a45c11",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health's (CAH) vertical integration of \"higher-growth and higher-margin services\" will comp",
                "category": "company",
                "datetime": 1787155323,
                "headline": "Cardinal Health's Integration of Higher-Margin Services Will Drive Outperformance, RBC Says"
              },
              {
                "id": 141255098,
                "url": "https://finnhub.io/api/news?id=407cd590acc44067e69ec21c3b5d573dbff31e348a254be4edac3e8cfcac88f4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Moderna upgraded, Baidu downgraded: Wall Street's top analyst calls",
                "category": "company",
                "datetime": 1787150302,
                "headline": "Moderna upgraded, Baidu downgraded: Wall Street's top analyst calls"
              },
              {
                "id": 141259500,
                "url": "https://finnhub.io/api/news?id=cb4ae7c43fea7b23d204dbd5f2a4b5ea60ff0d71b6a43a109dfaf6de68fb5c7e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Markets turned south again Wednesday as surging yields and geopolitical fears rattled investors, but Wall Street analysts spotted opportunity and danger in names like Baidu, Klarna, Honeywell Aerospace, and Dollar Tree that traders need to see before the open.",
                "category": "company",
                "datetime": 1787144196,
                "headline": "Here Are Wednesday’s Top Wall Street Analyst Research Calls: Baidu, Ciena, CME Group, Dollar Tree, Dominion, Fabrinet, Honeywell Aerospace, Klarna, Pershing Square, and More"
              },
              {
                "id": 141253695,
                "url": "https://finnhub.io/api/news?id=3c3066b7a556a34c1a084c681d5941596afec66a3fdaf375963338e9d1e32f6d",
                "image": "",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "RBC Capital  analyst Ryan Halsted   initiates coverage on Cardinal Health (NYSE:CAH) with a Outperform rating and announces Price Target of $276.",
                "category": "company",
                "datetime": 1787132694,
                "headline": "RBC Capital Initiates Coverage On Cardinal Health with Outperform Rating, Announces Price Target of $276"
              },
              {
                "id": 141253214,
                "url": "https://finnhub.io/api/news?id=55b2612597751aff2579b02d0a94b174d997e251973f5cbbcbbb21cc957e62b9",
                "image": "",
                "source": "SeekingAlpha",
                "related": "CAH",
                "summary": "",
                "category": "company",
                "datetime": 1787129746,
                "headline": "Cardinal Health: Precision Medicine Drives A Sustained Revenue Growth Path"
              },
              {
                "id": 141279877,
                "url": "https://finnhub.io/api/news?id=c47505c3dc9586b3a6348210ab896b422c8c06eda61b4c18fa117bc974b4f9e2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "OPK raises $125 million against mazdutide royalties, gaining non-dilutive capital while retaining longer-term royalty upside.",
                "category": "company",
                "datetime": 1787077380,
                "headline": "OPKO Health Secures $125 Million Financing Against Mazdutide Royalties"
              },
              {
                "id": 141281564,
                "url": "https://finnhub.io/api/news?id=f6f0cb7498e1d33d53716ba1b2fe269651b58bc632951f6ab547d308849691eb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "GLP-1 tailwinds and specialty strength drove pharma profit up 21% in Q4.",
                "category": "company",
                "datetime": 1787067813,
                "headline": "Cardinal Health (CAH) Q4 2026 Earnings Call Transcript"
              },
              {
                "id": 141281565,
                "url": "https://finnhub.io/api/news?id=aa7893dba0b7ba30e6775070e552e7c107e3b8b80c13bda3b71dc4b7e59ba2ba",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Anita Zielinski will join Cardinal Health in November as its new chief accounting officer.",
                "category": "company",
                "datetime": 1787055182,
                "headline": "Baxter’s interim CFO leaves for Cardinal Health"
              },
              {
                "id": 141281566,
                "url": "https://finnhub.io/api/news?id=8059c2d2ad511cac4cd33d5903fdb21dd7fbe90810769d4eacc4c628e23c26e5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health’s second quarter results reflected strong profit growth, despite revenue falling short of Wall Street’s expectations. Management credited broad-based demand in its Pharmaceutical and Specialty Solutions segment, stable operating margins, and continued progress on its improvement plan in the Global Medical Products and Distribution unit as key performance drivers. CFO Aaron Alt called out “strong demand, strong execution, strong profit,” highlighting the company’s ability to deliv",
                "category": "company",
                "datetime": 1787043453,
                "headline": "5 Revealing Analyst Questions From Cardinal Health’s Q2 Earnings Call"
              },
              {
                "id": 141281572,
                "url": "https://finnhub.io/api/news?id=9cc59241381a967f196ccd02f616c9c312113bf0d32eb77878540773004d7acd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.",
                "category": "company",
                "datetime": 1786988703,
                "headline": "3 Reasons Growth Investors Will Love Cardinal (CAH)"
              },
              {
                "id": 141237777,
                "url": "https://finnhub.io/api/news?id=7c05a7bfce72694815f544e874b23f60dca0c5bfcc88c83bdc9eab942fd3c0e6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.",
                "category": "company",
                "datetime": 1786841580,
                "headline": "1 S&P 500 Stock Worth Investigating and 2 We Turn Down"
              },
              {
                "id": 141223241,
                "url": "https://finnhub.io/api/news?id=33a2434b268e9c2c0fa89571638f2150a7ee2e9c0b89bccb945d9e3a0e34de88",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Bristol-Myers Squibb trades at less than half the valuation multiple of AbbVie, but AbbVie's revenue growth tells a different story about future earnings power.",
                "category": "company",
                "datetime": 1786736789,
                "headline": "AbbVie vs. Bristol-Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 141237771,
                "url": "https://finnhub.io/api/news?id=e17fa0d13076a4a8bd279c74b3e414d9f3501a2dc67174b4a2bce7c8b3aa49ce",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Jason Hollar, Cardinal Health (CAH) CEO joins Yahoo Finance Executive Editor Brian Sozzi to detail how M&A strategy, specialty pharma growth, and drug volume dynamics are driving profits.",
                "category": "company",
                "datetime": 1786732188,
                "headline": "Cardinal Health CEO details M&A strategy and growth"
              },
              {
                "id": 141237778,
                "url": "https://finnhub.io/api/news?id=367a84c2f8076f5a8bad9804ededf729b3319df5dfda2f5bb74e17f5d37735d7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "HNGE's strong revenue growth, raised 2026 outlook and expansion into Migraine and GI care support its growth prospects despite investment pressures.",
                "category": "company",
                "datetime": 1786721760,
                "headline": "Reasons to Hold Hinge Health Stock in Your Portfolio for Now"
              },
              {
                "id": 141237779,
                "url": "https://finnhub.io/api/news?id=e344598255c9673102ba1313d573d1c3a3aa83d0bc7043f35aeaa1663a617a7e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Solventum plans to spin off its $1.4B HIS business, sharpening its MedTech focus while giving HIS more flexibility to pursue growth.",
                "category": "company",
                "datetime": 1786721700,
                "headline": "SOLV Plans Health Information Systems Business Spinoff to Drive Growth"
              },
              {
                "id": 141237780,
                "url": "https://finnhub.io/api/news?id=bb5d54af2d975e1d0735d6f3c1a639d678139f27cb2646fee50303085609a3dd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "CVS Health advances its $20 billion technology push with AI tools, Health100 and automation aimed at simplifying care and improving engagement.",
                "category": "company",
                "datetime": 1786718340,
                "headline": "How CVS Is Building on Its Consumer-Health Care Technology Push"
              },
              {
                "id": 141237775,
                "url": "https://finnhub.io/api/news?id=a4bceb6094e64669174ffe675842af9d12ccc8f13e47a1a88b434206e3cc4192",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Healthcare distributor and services company Cardinal Health (NYSE:CAH) fell short of the market’s revenue expectations in Q2 CY2026, but sales rose 5.8% year on year to $63.67 billion. Its non-GAAP profit of $2.60 per share was 7.4% above analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1786718220,
                "headline": "CAH Q2 CY2026 Deep Dive: Specialty Momentum, Strategic Investments, and Guidance Above Street Expectations"
              },
              {
                "id": 141237781,
                "url": "https://finnhub.io/api/news?id=f9e26e1d7842ce5bcadb6ab5942b24de626a56dfb0bf3390b7003be284bc425f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Here is how BioMarin Pharmaceutical (BMRN) and Cardinal Health (CAH) have performed compared to their sector so far this year.",
                "category": "company",
                "datetime": 1786714802,
                "headline": "Is BioMarin Pharmaceutical (BMRN) Outperforming Other Medical Stocks This Year?"
              },
              {
                "id": 141237782,
                "url": "https://finnhub.io/api/news?id=bfbc65f21c26c1d88a19ea9c089289af8c87bd78d8db8c3f88fb891bca7fb305",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Monolithic Power Systems is benefiting from surging AI demand, while Las Vegas Sands faces earnings pressure and a prolonged downtrend.",
                "category": "company",
                "datetime": 1786699680,
                "headline": "Monolithic Power Systems and Las Vegas Sands have been highlighted as Zacks Bull and Bear of the Day"
              },
              {
                "id": 141215083,
                "url": "https://finnhub.io/api/news?id=598a7584576f7c61713e7621fce46c4faa8fbe12fa1ed4b413f52bec8de4fa49",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Keurig Dr Pepper has recently reported second-quarter 2026 results showing sales of US$7.31 billion and net income of US$142 million, while rolling out a lime-led reformulation of 7UP and partnering with Portillo’s on limited-time Dr Pepper shakes in the U.S. Alongside these product moves, the company has added Cardinal Health CFO Aaron Alt to its board as it works through a planned split into separate beverage and coffee businesses. With Aaron Alt joining the board during Keurig Dr Pepper’s...",
                "category": "company",
                "datetime": 1786684378,
                "headline": "Did New 7UP Formula, Dr Pepper Shakes and Board Addition Just Shift Keurig Dr Pepper's (KDP) Investment Narrative?"
              },
              {
                "id": 141212244,
                "url": "https://finnhub.io/api/news?id=a9b9bac25f326babf2cf9fff8b8b91c7e59caef31b954bb8195e667417086299",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (CAH) gave investors plenty to like in its fiscal fourth-quarter report this week, sending shares to a record high of $258 as Wall Street digests another earnings beat and an encouraging FY27 outlook.",
                "category": "company",
                "datetime": 1786659000,
                "headline": "Cardinal Health Stock Hits a Record High After Earnings: Is CAH Still a Buy?"
              },
              {
                "id": 141206709,
                "url": "https://finnhub.io/api/news?id=abf15460060e9d68def7ae24c3778a414925e71cb70a7b8f3956a47e4e500adc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "RVTY launches SuperFlex, a compact automated prenatal screening system aimed at expanding rapid in-house testing for smaller labs and clinics.",
                "category": "company",
                "datetime": 1786629600,
                "headline": "Revvity Launches SuperFlex Prenatal Screening System for Smaller Labs"
              },
              {
                "id": 141206710,
                "url": "https://finnhub.io/api/news?id=abedfdde25a71c7c7bc1ec24877b35a2308165097b57dd2eb20ad3baf6d15d97",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "BWXT expands its commercial nuclear portfolio through nuclear medicine, isotope production and radiopharmaceutical capabilities.",
                "category": "company",
                "datetime": 1786627740,
                "headline": "Can BWX Technologies' Nuclear Medicine Expansion Boost Growth?"
              },
              {
                "id": 141205666,
                "url": "https://finnhub.io/api/news?id=6ffa1b74e3016ee2e16dcae1b326a2ce32afa731ce1bdc8b5deda915bb26d23a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cooper Companies' premium lens migration, MiSight growth and fertility recovery offer long-term upside despite Asia-Pacific, tariff and FX pressures.",
                "category": "company",
                "datetime": 1786625460,
                "headline": "Here's Why You Should Add Cooper Companies Stock to Your Portfolio Now"
              },
              {
                "id": 141210182,
                "url": "https://finnhub.io/api/news?id=d02e20668bac91e5753df1cfdd25b1a27d8f65f5de1aa361f4d94b5700da9a7c",
                "image": "",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "TD Cowen  analyst Charles Rhyee   maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $275 to $280.",
                "category": "company",
                "datetime": 1786624820,
                "headline": "TD Cowen Maintains Buy on Cardinal Health, Raises Price Target to $280"
              },
              {
                "id": 141210183,
                "url": "https://finnhub.io/api/news?id=7576f9f932bb59b8c3ba7a2a7053bed1cc431fdd6bf519c8bc241a384e39456f",
                "image": "",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "JP Morgan  analyst Lisa Gill   maintains Cardinal Health (NYSE:CAH) with a Neutral and raises the price target from $215 to $260.",
                "category": "company",
                "datetime": 1786618840,
                "headline": "JP Morgan Maintains Neutral on Cardinal Health, Raises Price Target to $260"
              },
              {
                "id": 141210184,
                "url": "https://finnhub.io/api/news?id=2b9f4a5fe586ea200658b80f283a448de66680f9c25eba48f4a78241ef76bd47",
                "image": "",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "Barclays  analyst Glen Santangelo   maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $258 to $275.",
                "category": "company",
                "datetime": 1786615346,
                "headline": "Barclays Maintains Overweight on Cardinal Health, Raises Price Target to $275"
              },
              {
                "id": 141205464,
                "url": "https://finnhub.io/api/news?id=9f7ff6539821a046024fff74df69023f2b0ecbb23b4e089ad7ae8966da039618",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1391441819/image_1391441819.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "CAH",
                "summary": "Cardinal Health (CAH) FY2026 EPS beat and margin shift to specialty drive FY2027 growth outlook. Click to read more about the pros and cons of investing in this company.",
                "category": "company",
                "datetime": 1786614786,
                "headline": "Cardinal Health: Q4 Presents Positive Signal For The Company's Long-Term Growth"
              },
              {
                "id": 141202025,
                "url": "https://finnhub.io/api/news?id=22eea6402014929c0f36f13688e8fe800f6307f7d21c4ce3ebb25dde2198951f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "After a very strong multi year run, Cardinal Health stock is now being judged by a low overall value score and fresh questions about risk controls, so investors are weighing whether the current price still fairly reflects its fundamentals. Cardinal Health has delivered about 409.2% over the past 5 years, which sets expectations high for what comes next. The recent levothyroxine tablet recalls and the appointment of a new Chief Accounting Officer may affect how the market prices Cardinal...",
                "category": "company",
                "datetime": 1786561927,
                "headline": "Cardinal Health (CAH) Stock Looks About Right On Earnings But Stretched On Broader Checks"
              },
              {
                "id": 141202026,
                "url": "https://finnhub.io/api/news?id=97ab54c918f28076744a4e5ca52afd74f952462e18a373fe366ed574dd99f47a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health targets 13%-15% fiscal 2027 EPS growth as pharma demand normalizes and specialty, At-Home and buybacks remain key priorities for execution.",
                "category": "company",
                "datetime": 1786543200,
                "headline": "CAH Q4 Earnings Call Centers on Fiscal 2027 Growth Outlook"
              },
              {
                "id": 141197398,
                "url": "https://finnhub.io/api/news?id=9df59528a4a2ee87540fc0366a30ef404591320cc5d0a4c8cefc1280bbac323b",
                "image": "",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "Evercore ISI Group  analyst Elizabeth Anderson   maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $265 to $270.",
                "category": "company",
                "datetime": 1786536377,
                "headline": "Evercore ISI Group Maintains Outperform on Cardinal Health, Raises Price Target to $270"
              },
              {
                "id": 141201851,
                "url": "https://finnhub.io/api/news?id=35ed6ea51c03ade38ff6c9e33b05dc209517480370a588a46e546909ad7de48f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Keurig Dr Pepper Inc. (NASDAQ: KDP) announced today that Aaron Alt has been appointed a director of the Company's Board of Directors, effective August 14, 2026.",
                "category": "company",
                "datetime": 1786536000,
                "headline": "Keurig Dr Pepper Announces Appointment of New Director to its Board"
              },
              {
                "id": 141197399,
                "url": "https://finnhub.io/api/news?id=02b06fe7d11ab56154976de3659472c0a117b726da681545990a1dd538e24306",
                "image": "",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "Morgan Stanley  analyst Erin Wright   maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $255 to $265.",
                "category": "company",
                "datetime": 1786535411,
                "headline": "Morgan Stanley Maintains Overweight on Cardinal Health, Raises Price Target to $265"
              },
              {
                "id": 141202027,
                "url": "https://finnhub.io/api/news?id=30ce0753849b88205da5edf92724d076b6da8f051f4a3319cf7296393178ab69",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Companies In The Article Are:FRMI,CAH,PLUG and ARMK",
                "category": "company",
                "datetime": 1786533720,
                "headline": "Company News for Aug 12, 2026"
              },
              {
                "id": 141197400,
                "url": "https://finnhub.io/api/news?id=c18d4ebfc09385ef17ef9501ad941fd75e935b81694ed1a68328227f434dacbd",
                "image": "",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "Mizuho  analyst Steven Valiquette   maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $240 to $250.",
                "category": "company",
                "datetime": 1786528212,
                "headline": "Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $250"
              },
              {
                "id": 141197401,
                "url": "https://finnhub.io/api/news?id=105192d4ab34f64425336b0976e542178f647c63348738cf86b673150296c25b",
                "image": "",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "UBS  analyst Kevin Caliendo   maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $274 to $280.",
                "category": "company",
                "datetime": 1786525990,
                "headline": "UBS Maintains Buy on Cardinal Health, Raises Price Target to $280"
              },
              {
                "id": 141197402,
                "url": "https://finnhub.io/api/news?id=0fdf9ee2f288d9ea96f7ee60f438733dc0a3c25dc438e454b616ebdd965628da",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/12/Cardinal-Health-Logo-Sign-On-The-Buildin.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "Cardinal Health posted mixed Q4 results, with adjusted earnings of $2.91 per share beating estimates, but sales missing expectations. The company also raised its share repurchase authorization and expects strong earnings in fiscal 2027.",
                "category": "company",
                "datetime": 1786523319,
                "headline": "Cardinal Health Analysts Increase Their Forecasts Following Q4 Results"
              },
              {
                "id": 141197403,
                "url": "https://finnhub.io/api/news?id=4730b2f566fe85a960dab68352b52e04c6b8c0af25003482fba1daae41417c73",
                "image": "",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "Wells Fargo  analyst Stephen Baxter   maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $245 to $277.",
                "category": "company",
                "datetime": 1786522841,
                "headline": "Wells Fargo Maintains Overweight on Cardinal Health, Raises Price Target to $277"
              },
              {
                "id": 141197404,
                "url": "https://finnhub.io/api/news?id=aa4b0f62d1d592589ddff545dc7539b9bc32845027cea67ef67757e150840262",
                "image": "",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "Baird  analyst Eric Coldwell   maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $251 to $274.",
                "category": "company",
                "datetime": 1786516098,
                "headline": "Baird Maintains Outperform on Cardinal Health, Raises Price Target to $274"
              },
              {
                "id": 141195284,
                "url": "https://finnhub.io/api/news?id=3bba5616233a12492b2aa603475d0cd7c3d32519ffe39c47e0837ea572ef9c69",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/12/Market-sentiment---Fear-and-Greed.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "CNN Fear & Greed Index: Market sentiment declined, but remained in Greed zone on Tuesday. Stocks closed lower.",
                "category": "company",
                "datetime": 1786503447,
                "headline": "S&P 500 Falls for Second Session Ahead of Inflation Report: Investor Sentiment Weakens, Fear & Greed Index Remains in ‘Greed’ Zone"
              },
              {
                "id": 141202028,
                "url": "https://finnhub.io/api/news?id=fd2393645d02461718a1549810242eea6f667e802dc0cbca28d8c0a6cd329e03",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health Inc (CAH) delivered a stellar Q4 with 40% EPS growth, driven by strong segment performance and a $5 billion free cash flow year.",
                "category": "company",
                "datetime": 1786482195,
                "headline": "Cardinal Health Inc (CAH) (Q4 2026) Earnings Call Highlights: Record EPS Growth and Robust ..."
              },
              {
                "id": 141200621,
                "url": "https://finnhub.io/api/news?id=a08e7c7fa18be82606ea2feeb7ddeeada1626fe5e95e301c926252196ccedab8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "AbbVie commands a premium valuation for its specialty drug pipeline, while CVS Health trades at a discount despite managing 37 million medical members.",
                "category": "company",
                "datetime": 1786481221,
                "headline": "AbbVie vs. CVS Health: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 141202030,
                "url": "https://finnhub.io/api/news?id=4de1e1ed2837fd8d3f9f1a553bb4c4147838b01c0689eaaf376d96ecb417df71",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Healthcare distributor and services company Cardinal Health (NYSE:CAH) will be announcing earnings results this Tuesday before market hours. Here’s what to expect.",
                "category": "company",
                "datetime": 1786480162,
                "headline": "Earnings To Watch: Cardinal Health (CAH) Reports Q2 Results Tomorrow"
              },
              {
                "id": 141202031,
                "url": "https://finnhub.io/api/news?id=9dc21f5d020c48bba19f15732a9c1eb5f518d86a66375c4e2c4091bb360e5762",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health stock jumped Tuesday after the medical wholesaler's fiscal 2027 guidance handily beat Wall Street's expectations.",
                "category": "company",
                "datetime": 1786478763,
                "headline": "Cardinal Health Bolts Higher Despite Mixed Earnings. Here's Why."
              },
              {
                "id": 141202032,
                "url": "https://finnhub.io/api/news?id=6d8df3156489a84fb74ea99d879518702d0765986bdb37f415727f77c0e90aee",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Moby summary of Cardinal Health, Inc.'s Q4 2026 earnings call",
                "category": "company",
                "datetime": 1786469128,
                "headline": "Cardinal Health, Inc. Q4 2026 Earnings Call Summary"
              },
              {
                "id": 141201489,
                "url": "https://finnhub.io/api/news?id=e53a74fb978cb94b10738c9262b2a96baa6fac4eef3538f1a98cc3c9da000745",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (NYSE:CAH) reported fourth-quarter fiscal 2026 results marked by growth in revenue, operating earnings and adjusted earnings per share, supported by demand in its pharmaceutical and specialty businesses and a one-time tariff-related benefit in its medical products segment. For the q",
                "category": "company",
                "datetime": 1786467870,
                "headline": "Cardinal Health Q4 Earnings Call Highlights"
              },
              {
                "id": 141202034,
                "url": "https://finnhub.io/api/news?id=c70632c2f9259acf971a4ff2e21f3a79f70231e7041cbbc36844dbb90356e0cf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health beats fiscal Q4 EPS estimates as profit surges, while revenues miss; fiscal 2027 guidance points to continued earnings growth.",
                "category": "company",
                "datetime": 1786465260,
                "headline": "CAH Q4 Earnings Beat on Pharma Strength, Revenues Miss, Stock Up"
              },
              {
                "id": 141202035,
                "url": "https://finnhub.io/api/news?id=5b2009080943f484ca312cf2ddae85582953343181666e7127ac9f3833e34b70",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "RadNet tops Q2 estimates as advanced imaging and Digital Health growth accelerate, prompting a higher 2026 Imaging Center outlook.",
                "category": "company",
                "datetime": 1786461600,
                "headline": "RDNT Q2 Earnings & Sales Beat on Advanced Imaging, Guidance Raised"
              },
              {
                "id": 141188422,
                "url": "https://finnhub.io/api/news?id=71a5a0af29a0a7d871f7407396fabbf5f8632ff38350b922b2a3bc321bca3b91",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Existing Home Sales Data in Focus",
                "category": "company",
                "datetime": 1786459440,
                "headline": "Existing Home Sales Data in Focus"
              },
              {
                "id": 141202037,
                "url": "https://finnhub.io/api/news?id=09629c4111d96208aa545e89c200a2b9212e36d3002832b633e27c2ce0f6ad45",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health reports mixed quarterly performance across its business segments as earnings get a lift from one-time tariff refunds.",
                "category": "company",
                "datetime": 1786457580,
                "headline": "Why Cardinal Health Stock Is Heading for a Record After Mixed Earnings"
              },
              {
                "id": 141188424,
                "url": "https://finnhub.io/api/news?id=b3fac852b65d9326a92d04d5b7ccacdb42bc4206e21c1033b0575812e02a99d1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "We don't expect much movement either direction until inflation reports begin to hit the tape Wednesday morning.",
                "category": "company",
                "datetime": 1786457580,
                "headline": "Small Biz Index, Existing Home Sales & More Earnings"
              },
              {
                "id": 141202039,
                "url": "https://finnhub.io/api/news?id=28e4ec0fdd8c9d1b920d2e1bb19779e52ff45363ce8688cc19e2dfbcca2f3cdf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "AdaptHealth (NASDAQ:AHCO) executives outlined the company’s second-quarter performance, portfolio changes and plans to focus capital on sleep, respiratory and home medical equipment businesses during a Canaccord conference discussion. Chief Executive Officer Suzanne Foster said the company has spen",
                "category": "company",
                "datetime": 1786457078,
                "headline": "AdaptHealth Sells Diabetes Unit to Sharpen Focus on Sleep, Respiratory Growth"
              },
              {
                "id": 141202040,
                "url": "https://finnhub.io/api/news?id=42984f3bbfa0be04c727538d088a1bef44aa34e5cb16a7df83d1dc125ebd73ab",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Although the revenue and EPS for Cardinal (CAH) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
                "category": "company",
                "datetime": 1786455002,
                "headline": "Compared to Estimates, Cardinal (CAH) Q4 Earnings: A Look at Key Metrics"
              },
              {
                "id": 141201490,
                "url": "https://finnhub.io/api/news?id=b27d87e3c8947f158bf4d832fe91f3e13a1b1c088d17bd7f1566ddeb622996ec",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "S&P 500 drug distributor Cardinal Health easily topped fiscal fourth-quarter earnings forecasts despite a revenue shortfall.  Rival McKesson, which whipsawed after its earnings report last week, has climbed back near a buy point.  Cencora, another big S&P 500 drug distributor, also is near a buy point, but MCK stock may be the strongest of the three.",
                "category": "company",
                "datetime": 1786454176,
                "headline": "S&P 500 Medical Stocks: Three Trade Near Buy Points; One Rallies Despite Mixed Results"
              },
              {
                "id": 141202042,
                "url": "https://finnhub.io/api/news?id=474b04222fa42c42adc40020ed5b369590266ba159ca9be764d437b5b3fb6c4f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health Inc. (NYSE:CAH) shares advanced in pre-market trading on Tuesday after the healthcare company delivered better-than-expected fourth-quarter earnings and issued fiscal 2027 profit guidance above Wall Street forecasts.",
                "category": "company",
                "datetime": 1786452860,
                "headline": "Cardinal Health shares rise 4% as profit beats estimates and 2027 outlook tops forecasts"
              },
              {
                "id": 141185357,
                "url": "https://finnhub.io/api/news?id=ff52b65f46f6082824002e0e6919374e211348aea34f371286525b16abfd839e",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "CAH",
                "summary": "Cardinal Health, Inc. (CAH) Q4 2026 Earnings Call August 11, 2026 8:30 AM EDTCompany ParticipantsDavid Frost - Vice President of Finance, Global Operations...",
                "category": "company",
                "datetime": 1786449439,
                "headline": "Cardinal Health, Inc. (CAH) Q4 2026 Earnings Call Transcript"
              },
              {
                "id": 141202043,
                "url": "https://finnhub.io/api/news?id=211c1e69d0f065f870c9c010a432db201c6207fc440f7474867a1efe9b423f3a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal (CAH) delivered earnings and revenue surprises of +20.25% and -2.96%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1786449302,
                "headline": "Cardinal Health (CAH) Q4 Earnings Beat Estimates"
              },
              {
                "id": 141185209,
                "url": "https://finnhub.io/api/news?id=512cb5e3c45f8dd23e0f741191a2f85925d30cb818018ad7e2e80ee8846b5488",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2205618145/image_2205618145.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "CAH",
                "summary": "U.S. equity markets rebounded strongly this week, with gains led by technology and growth-oriented sectors.",
                "category": "company",
                "datetime": 1786448940,
                "headline": "ValuEngine Weekly Market Summary And Commentary"
              },
              {
                "id": 141188425,
                "url": "https://finnhub.io/api/news?id=27b10362ca2ded8a47c4824b2623a4231b6abbbe3ac3bde3211b6cf61ef16595",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "US equity markets were mostly trending higher before the open Tuesday as investors weigh fading opti",
                "category": "company",
                "datetime": 1786448901,
                "headline": "Stocks Mostly Up Pre-Bell as Investors Assess Uncertainty Over US-Iran Deal"
              },
              {
                "id": 141185934,
                "url": "https://finnhub.io/api/news?id=fe4c1e061496cbe2360f85c95eb7fc615f8133f7a493824e76960b28cc173d9a",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/11/Cardinal-Health-Logo-Sign-On-The-Buildin.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "CAH stock hits new 52-week high as Cardinal Health beats Q4 earnings, boosts FY27 outlook, and approves a $5B buyback expansion.",
                "category": "company",
                "datetime": 1786443092,
                "headline": "Cardinal Health Says It Now Exclusively Serves Nearly Half The Cell-And-Gene Therapy Market"
              },
              {
                "id": 141185034,
                "url": "https://finnhub.io/api/news?id=1054c33353bcd92d23e844c1a4197b83502525bc96f2dac36f07a9c68dd2486b",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/11/Portland--Or--Usa---Mar-12--2020-Dow-Jon.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "US stocks mixed, Dow up 150 points. Industrials gain 1%, communication services fall 1.1%. Cardinal Health (NYSE: CAH) up 8%. Oil up 0.4%, gold up 0.6%.",
                "category": "company",
                "datetime": 1786441930,
                "headline": "US Stocks Mixed; Cardinal Health Shares Jump After Q4 Results"
              },
              {
                "id": 141184355,
                "url": "https://finnhub.io/api/news?id=fb04464bbf2469f77fdd0a463b7f84f91d3d25ff58a7573e67ca36792c7ab374",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "CAH",
                "summary": "2026-08-11. The following slide deck was published by Cardinal Health, Inc.",
                "category": "company",
                "datetime": 1786438886,
                "headline": "Cardinal Health, Inc. 2026 Q4 - Results - Earnings Call Presentation"
              },
              {
                "id": 141185821,
                "url": "https://finnhub.io/api/news?id=644bced8e675f77e9638aa6f88b5d7b70aab964d554a2b174c2fa7c25f6766b7",
                "image": "https://image.cnbcfm.com/api/v1/image/108078990-1734724223663-gettyimages-2175241235-PGONCHAR_9141.jpeg?v=1734724254&w=1920&h=1080",
                "source": "CNBC",
                "related": "CAH",
                "summary": "These are the stocks posting the largest moves premarket.",
                "category": "company",
                "datetime": 1786432530,
                "headline": "Stocks making the biggest moves premarket: Riot Platforms, Hims & Hers Health, Intel & more"
              },
              {
                "id": 141185936,
                "url": "https://finnhub.io/api/news?id=610dec45de326b7eb81c754e0d987cd182064060b9a1021bf8ec96720b806df1",
                "image": "",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "Cardinal Health recently completed an additional $350 million accelerated share repurchase program, bringing year-to-date share repurchases in fiscal year 2026 to $1.4 billion.Cardinal Health Board of Directors approved",
                "category": "company",
                "datetime": 1786431077,
                "headline": "Cardinal Health Announces $5B Incremental Share Buyback Authorization"
              },
              {
                "id": 141185937,
                "url": "https://finnhub.io/api/news?id=8ec34dd27410ba2b2bcb1b7175cdce377484b75d70454323f07d99ee2f169a80",
                "image": "",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "Cardinal Health (NYSE:CAH) is looking for FY2027 Adj EPS of $12.40-$12.60 vs $12.04 analyst estimate..",
                "category": "company",
                "datetime": 1786430759,
                "headline": "Cardinal Health Sees FY2027 Adj EPS $12.40-$12.60 vs $12.04 Est"
              },
              {
                "id": 141184828,
                "url": "https://finnhub.io/api/news?id=d483448f18761861e3a4df5857533c70e3540f74381ef15c1e0a76e3d2f6c4cd",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/11/Fear-and-Greed.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "Stocks closed mostly lower on Monday, with the Fear and Greed index remaining in Greed zone. Investors await earnings results and CPI report.",
                "category": "company",
                "datetime": 1786419882,
                "headline": "Dow Falls Over 50 Points Ahead of Inflation Data: Fear Index Remains in ‘Greed’ Zone"
              },
              {
                "id": 141184829,
                "url": "https://finnhub.io/api/news?id=8698c792cebd396ed088a8f639bc0e0e3e3f14224585e9e62a7f4f1966a70c8a",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/11/Cardinal-Health.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "U.S. stock futures mixed, focus on Super Micro Computer Inc, Upwork Inc, Cardinal Health Inc, Babcock & Wilcox Enterprises Inc.",
                "category": "company",
                "datetime": 1786419773,
                "headline": "Cardinal Health, Babcock & Wilcox Enterprises and 3 Stocks to Watch Heading Into Tuesday"
              },
              {
                "id": 141185940,
                "url": "https://finnhub.io/api/news?id=cbe7ec07e8d3c7bcb8bcca73204d6b920711dcde0ba3ae293104d789345ed923",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/11/Cardinal-Health-Logo-Sign-On-The-Buildin.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "CAH to release Q4 earnings on Aug. 11, analysts expect EPS of $2.42 and revenue of $65.11B. Recently acquired diabetes health business for $360M.",
                "category": "company",
                "datetime": 1786413995,
                "headline": "Cardinal Health Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts"
              },
              {
                "id": 141177635,
                "url": "https://finnhub.io/api/news?id=2e87455abaf1fa312c423f3bfe57322bf443a81c6e419773c587559f5d9f5133",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "QuidelOrtho beats Q2 earnings and revenue estimates, but cuts its 2026 outlook on persistent China weakness and a softer respiratory testing environment.",
                "category": "company",
                "datetime": 1786382940,
                "headline": "QDEL Q2 Earnings & Revenues Beat Estimates, 2026 Guidance Lowered"
              },
              {
                "id": 141177636,
                "url": "https://finnhub.io/api/news?id=ffdfab5d91e411887bc6414fe5e00badc391012530468522e6572447588ee92f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "ITGR beats Q2 earnings and revenue estimates, but sales and margins decrease as product headwinds persist ahead of its $5.7B KKR deal.",
                "category": "company",
                "datetime": 1786382820,
                "headline": "Integer Holdings Q2 Earnings & Revenues Top Estimates, Margins Decline"
              },
              {
                "id": 141177784,
                "url": "https://finnhub.io/api/news?id=2b214d626c55d69f3321fcb009f6866c20e2d848f4d640c809751929b9c57eb4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "INGN's Q2 revenues rise 3% as international sales climb 14.8%, but U.S. weakness led it to cut its 2026 revenue outlook.",
                "category": "company",
                "datetime": 1786380840,
                "headline": "Inogen Q2 Earnings Beat Estimates, Sales Rise Y/Y, 2026 View Cut"
              },
              {
                "id": 141176776,
                "url": "https://finnhub.io/api/news?id=51215d10973a1d3873da231aeeefd48c6bc09a21e18da33bfd7c86363e77526d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "IRTC posts 20.1% revenue growth, margin expansion and a higher 2026 outlook while advancing innovation and its Vital Connect acquisition.",
                "category": "company",
                "datetime": 1786379820,
                "headline": "iRhythm Q2 Earnings Beat Estimates on Volume Growth, '26 View Raised"
              },
              {
                "id": 141178046,
                "url": "https://finnhub.io/api/news?id=9cb8903118b9fe62e7cf5a7b40a69de9e912ad595d9d2c9391742cabefa7f5bd",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/10/Quarterly-Results-Sales-Profits-Earnings.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "CAH",
                "summary": "Earnings set to hit the tape Tues. Options market implying post-print swings for 5 stocks, from healthcare to AI. Cardinal Health has biggest move at 6.83%.",
                "category": "company",
                "datetime": 1786375870,
                "headline": "Lumentum Could Swing $9.74 Billion After Earnings"
              },
              {
                "id": 141164926,
                "url": "https://finnhub.io/api/news?id=deff1d4247207aac2c94f55973825d0ce38ade9e08234210a6c7618171e2655c",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1389969538/image_1389969538.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "CAH",
                "summary": "Get ready for the week ahead: July CPI/PPI, retail sales, 13F filings, and key earnings (AMAT, CSCO).",
                "category": "company",
                "datetime": 1786245109,
                "headline": "Wall Street Week Ahead"
              },
              {
                "id": 141158812,
                "url": "https://finnhub.io/api/news?id=92ebcf9e88eb5cc5530a414cce8df0a9c9e063c37e41df80756b63479a5d5bdc",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "CAH",
                "summary": "Wall Street Week Ahead: key market events, CPI/retail data, earnings (Cisco, Tencent), IPOs & dividends after weak jobs report. See more details here.",
                "category": "company",
                "datetime": 1786186800,
                "headline": "Cisco, Tencent Headline Muted Earnings Week"
              },
              {
                "id": 141152474,
                "url": "https://finnhub.io/api/news?id=3852ba4223d6f6fd4381be34a82f8c1b6dd45b23181cf2e6ab311afb3d93f615",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "AbbVie generates stronger free cash flow and trades at a lower forward multiple, while Abbott offers diversification and a healthier balance sheet.",
                "category": "company",
                "datetime": 1786135497,
                "headline": "AbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026?"
              },
              {
                "id": 141151192,
                "url": "https://finnhub.io/api/news?id=fc7d6e4a19b1ecefa500bbfc8e2e25de6b5c94dd43bc59e1620796a4007a8a89",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "DENTSPLY SIRONA's Q2 sales fall 4.1% as dental weakness offsets Wellspect growth, while margins improve and 2026 guidance is maintained.",
                "category": "company",
                "datetime": 1786127700,
                "headline": "XRAY Stock Falls Despite Q2 Earnings Beat, Wellspect Drives Sales"
              },
              {
                "id": 141151124,
                "url": "https://finnhub.io/api/news?id=d7465a2a4c88ee05863f3b79d5beec80125a4c5b3f1728075ee3ed1c26c3ad57",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health heads into Q4 earnings with pharma, specialty and higher-margin businesses in focus as investors watch if growth offsets pricing headwinds.",
                "category": "company",
                "datetime": 1786126800,
                "headline": "Will Pharma and Specialty Demand Boost Cardinal Health's Q4 Results?"
              },
              {
                "id": 141151125,
                "url": "https://finnhub.io/api/news?id=0854f9893f7e0124ebd598160832596723151b50db3780060288d2e8256a7c06",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "TXG beats Q2 earnings and revenue estimates, expands gross margin and raises its 2026 revenue outlook despite a year-over-year sales decline.",
                "category": "company",
                "datetime": 1786125420,
                "headline": "10x Genomics Q2 Earnings & Revenues Beat Estimates, Gross Margin Up"
              },
              {
                "id": 141151126,
                "url": "https://finnhub.io/api/news?id=cfab742cf05cd6088afc2f50d6af7fb553f338ccdbaf70bfd1cdcd0559e40570",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "RGTI's Q2 revenues surge 185.3% and beat estimates, but widening losses and higher R&D and SG&A costs continue to pressure profitability.",
                "category": "company",
                "datetime": 1786125300,
                "headline": "Rigetti Q2 Earnings Miss Estimates on Higher Costs, Revenue Beat"
              },
              {
                "id": 141149609,
                "url": "https://finnhub.io/api/news?id=328e13ad11d15da6764538592fc4d871018f1a757eb98788f0e82e7cddc1f178",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "AMN Healthcare's Q2 EPS jumps 158% as revenues rise 2.3%, helped by travel nurse, allied and search growth plus labor disruption activity.",
                "category": "company",
                "datetime": 1786121220,
                "headline": "AMN Q2 Earnings Beat Estimates on Staffing and Search Growth, Stock Up"
              },
              {
                "id": 141149610,
                "url": "https://finnhub.io/api/news?id=8e5bd7fa2a58cd02c146fd34fccaed30767229053dcd7376a68126d672047d2f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Doximity raises fiscal 2027 revenue guidance as AI adoption and pharma demand fuel growth, even as higher AI investments pressure margins.",
                "category": "company",
                "datetime": 1786120560,
                "headline": "DOCS Q1 Earnings Miss on Higher AI Costs, Revenues Beat, FY27 View Up"
              },
              {
                "id": 141148301,
                "url": "https://finnhub.io/api/news?id=5a3c8ead071379aef9859d3f4a401d3e5be7ff5b02c536d8216d1e01a05f6ef8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "In early August 2026, Cardinal Health announced that Anita Zielinski will become Chief Accounting Officer in November, following her interim CFO and senior accounting roles at Baxter and long tenure at Sysco and Ernst & Young, while the company also faced ongoing Class II recalls of subpotent levothyroxine tablets distributed nationwide in the US. This combination of leadership change in Cardinal Health’s finance function and routine but nationwide product recalls comes as analysts are...",
                "category": "company",
                "datetime": 1786115683,
                "headline": "Does Cardinal Health’s New CAO and Recalls Reveal Shifts in Its Risk Profile and Earnings Quality (CAH)?"
              },
              {
                "id": 141152595,
                "url": "https://finnhub.io/api/news?id=1d12af0ff7855b8c1ab0215a085a52dda04bcd97546b0a74b828b2b1c6757c0b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "As Cardinal Health has outpaced relative to the broader market over the past year, Wall Street analysts maintain a strongly optimistic outlook about the stock’s prospects.",
                "category": "company",
                "datetime": 1786115655,
                "headline": "Are Wall Street Analysts Bullish on Cardinal Health Stock?"
              },
              {
                "id": 141148299,
                "url": "https://finnhub.io/api/news?id=0ac9c9438ddbdcb88fc0c9ca54d2e59e9d2176fc71420a41cad040cf6b50196f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
                "category": "company",
                "datetime": 1786110003,
                "headline": "Are Investors Undervaluing Cardinal Health (CAH) Right Now?"
              },
              {
                "id": 141148240,
                "url": "https://finnhub.io/api/news?id=1def74c37e95fb5383501555aa63fc8a7abb1562fe6f79afae08e538c51ffed9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
                "category": "company",
                "datetime": 1786108503,
                "headline": "Cardinal Health, Inc. (CAH) Hit a 52 Week High, Can the Run Continue?"
              },
              {
                "id": 141140627,
                "url": "https://finnhub.io/api/news?id=821a2ebea1801a2ec5b1d31db9ec33eb8b6e8f606927bd12df7b938a1445bd09",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "SOLV's Q2 earnings and revenues beat estimates as organic sales increase 9.5%, prompting higher 2026 guidance despite ERP timing benefits.",
                "category": "company",
                "datetime": 1786038780,
                "headline": "Solventum Stock Up as Q2 Earnings & Revenues Beat Estimates"
              },
              {
                "id": 141140628,
                "url": "https://finnhub.io/api/news?id=a8b9dcae545cc5c62870f85c5a89bc5758dc075833203dde38abaea6245b92f5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "PACB cuts its 2026 revenue outlook after Q2 sales fall 2%, as consumables and EMEA growth fail to offset weaker instruments and Asia-Pacific.",
                "category": "company",
                "datetime": 1786035840,
                "headline": "PacBio Q2 Earnings Meet Estimates, Revenues Miss, 2026 Sales View Cut"
              },
              {
                "id": 141137316,
                "url": "https://finnhub.io/api/news?id=f23c7f57565c87589923985dcfb23a36115479fe932f711cc0df05b80818daf2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "LIVN's Q2 earnings and revenues beat estimates as Cardiopulmonary and Epilepsy growth fuels margin gains and a raised 2026 outlook.",
                "category": "company",
                "datetime": 1786033860,
                "headline": "LivaNova Q2 Earnings & Revenues Beat Estimates, '26 Outlook Raised"
              },
              {
                "id": 141137317,
                "url": "https://finnhub.io/api/news?id=800e586663a06c21846fb4704cde171e522540f493e9141574d3def76d3d7334",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "McKesson shares rise after fiscal Q1 earnings and revenues beat estimates, powered by specialty growth, as the company raises its 2027 EPS outlook.",
                "category": "company",
                "datetime": 1786030860,
                "headline": "MCK Stock Up as Q1 Earnings Beat on Specialty Growth, Guidance Raised"
              },
              {
                "id": 141135657,
                "url": "https://finnhub.io/api/news?id=5a24d4fc7e20d2f42fbfa421ca5241dfaed6d6781e22798179d2f63aa814b815",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Beyond analysts' top-and-bottom-line estimates for Cardinal (CAH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2026.",
                "category": "company",
                "datetime": 1786022106,
                "headline": "Curious about Cardinal (CAH) Q4 Performance? Explore Wall Street Estimates for Key Metrics"
              },
              {
                "id": 141125909,
                "url": "https://finnhub.io/api/news?id=4cc57192c03dfc0eedad44bf9d950f4c8edb9fb26d63e7e6f813fcb1fdc036e2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "BDX's Medical Essentials and Interventional strength may drive third-quarter fiscal 2026 results, but China, vaccines and projected declines weigh on expectations.",
                "category": "company",
                "datetime": 1785952920,
                "headline": "Can Segment Strength Offset Headwinds for BD Stock Before Q3 Earnings?"
              },
              {
                "id": 141125845,
                "url": "https://finnhub.io/api/news?id=1f072d8bc81262c58fcde9ca14f0cd390a156475a76a63fa82afa3bf37326bfe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "TMDX's Q2 revenue beat and raised outlook are overshadowed by earnings miss, declining margins and sharply higher operating costs.",
                "category": "company",
                "datetime": 1785951720,
                "headline": "TransMedics Stock Dips Post Q2 Earnings Miss, Margins Contract"
              },
              {
                "id": 141124354,
                "url": "https://finnhub.io/api/news?id=3c99f0ca4df1360198bfda8776337250d51ac456a32bc832bac0b78ca6f14858",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Hinge Health's Q2 revenues jump 53% as stronger member yield, margin gains and raised 2026 guidance reinforce business momentum.",
                "category": "company",
                "datetime": 1785948000,
                "headline": "HNGE Q2 Earnings Meet Estimates, Sales Top, '26 View Raised, Stock Up"
              },
              {
                "id": 141122656,
                "url": "https://finnhub.io/api/news?id=026d8fb37247e734556ab139d7617d44722f4e154e1c54607e4041ad152a13a1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cencora's fiscal Q3 EPS beats estimates as broad segment growth lifts profit, prompting a higher 2026 outlook despite a slight revenue miss.",
                "category": "company",
                "datetime": 1785941400,
                "headline": "COR Stock Gains as Q3 Earnings Beat on Segment Growth, EPS View Raised"
              },
              {
                "id": 141122657,
                "url": "https://finnhub.io/api/news?id=d65126c035551814d108e50a1313d81a1237d5b5ba6733964cc3b8dad767605a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "FMS posts 28% EPS growth as Care Delivery profitability and margin gains offset a quarterly revenue miss and weaker US treatment volumes.",
                "category": "company",
                "datetime": 1785941340,
                "headline": "FMS Q2 Earnings Rise on Care Delivery, Revenues Miss, Margins Expand"
              },
              {
                "id": 141114964,
                "url": "https://finnhub.io/api/news?id=3a27c79bdda7dbd1818b7e5a6ed33774efec5c2b5603c9fd4a49454d569f3183",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Revvity beats Q2 earnings and sales estimates as Diagnostics growth, wider margins and strong cash flow support a higher 2026 outlook.",
                "category": "company",
                "datetime": 1785870540,
                "headline": "RVTY Q2 Earnings Beat Estimates on Diagnostics Strength, '26 View Up"
              },
              {
                "id": 141112034,
                "url": "https://finnhub.io/api/news?id=29220b2023579682d098f84e1a9bd930eeb6b970fa72c6152de3c809aefed06f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "INSP beats second-quarter estimates, raises its 2026 outlook and sees shares jump despite U.S. reimbursement pressures and lower revenues.",
                "category": "company",
                "datetime": 1785862680,
                "headline": "Inspire Medical Q2 Earnings Beat Estimates, '26 View Raised, Stock Up"
              },
              {
                "id": 141111972,
                "url": "https://finnhub.io/api/news?id=df094ae2eec47696320d6e89f3712c0176396b232d54ecfe5bd52264caebb772",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "XRAY's Q2 results are likely to reflect transformation investments, dealer inventory cuts and weak implants, while Wellspect growth offers support.",
                "category": "company",
                "datetime": 1785860520,
                "headline": "DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock?"
              },
              {
                "id": 141110254,
                "url": "https://finnhub.io/api/news?id=cb84813e06535b63d551fb93b0ba7740878d99f7865aa8ce432d0d80ee27b577",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal (CAH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1785852002,
                "headline": "Cardinal Health (CAH) Reports Next Week: Wall Street Expects Earnings Growth"
              },
              {
                "id": 141104313,
                "url": "https://finnhub.io/api/news?id=f014eaa7505c388d49e0c22bdd71b05a67073f41c62fb7861ce5dc604fefec86",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (CAH) closed the most recent trading day at $235.6, moving +2.42% from the previous trading session.",
                "category": "company",
                "datetime": 1785794402,
                "headline": "Cardinal Health (CAH) Outperforms Broader Market: What You Need to Know"
              },
              {
                "id": 141103171,
                "url": "https://finnhub.io/api/news?id=2dd88a54341cf14e6baa4cffeea6d4819a7bc50413f219d15c0c28b9d506a609",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "COR's Q3 results could reflect specialty pharma strength, oncology expansion and margin gains, even as pricing dynamics and GLP-1 trends pressure revenues.",
                "category": "company",
                "datetime": 1785783420,
                "headline": "Cencora to Report Q3 Earnings: Is a Beat Likely for the Stock?"
              },
              {
                "id": 141103123,
                "url": "https://finnhub.io/api/news?id=956f1718fa4a9368b5b1e1c2d0314e3d2f1156a72ea5cdc41fba63ace48f774f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "McKesson heads into Q1 with AI-driven efficiency, specialty momentum and oncology growth in focus as pricing dynamics may temper revenues.",
                "category": "company",
                "datetime": 1785783300,
                "headline": "Can AI-Driven Efficiency and Specialty Demand Boost MCK's Q1 Results?"
              },
              {
                "id": 141101106,
                "url": "https://finnhub.io/api/news?id=5abe8d9ae172747fe7022fcdf4b95538561fe7641d2aa18259c89c9f3cac727a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "SOLV's Q2 results are likely to benefit from segment strength, Acera gains and cost savings, offset by tariffs and ERP-related sales timing shifts.",
                "category": "company",
                "datetime": 1785774960,
                "headline": "Solventum to Report Q2 Earnings: What's in Store for the Stock?"
              },
              {
                "id": 141101012,
                "url": "https://finnhub.io/api/news?id=997f5ef6b2549b82d642e99554c1aea576c8afc47908049915f352f11bb26752",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "BTSG's Q2 earnings and revenues beat estimates as pharmacy and provider growth drive margin gains and a higher 2026 outlook.",
                "category": "company",
                "datetime": 1785773520,
                "headline": "BrightSpring Q2 Earnings Beat on Specialty Growth, '26 View Raised"
              },
              {
                "id": 141092960,
                "url": "https://finnhub.io/api/news?id=cc2823aed0c8324cf33e398f9cc96f74b50b6f28a6659645276bc7492e235898",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "CAH",
                "summary": "Cardinal Health (CAH) is back in focus for investors after a recent move in its share price, with the stock last closing at $230.03. The shift has sharpened attention on its valuation and fundamentals. See our latest analysis for Cardinal Health. Recent moves in Cardinal Health's share price sit against a stronger backdrop, with a 90 day share price return of 17.82% and a 1 year total shareholder return of 48.99%, which suggests momentum has been building despite a softer 30 day share price...",
                "category": "company",
                "datetime": 1785668940,
                "headline": "Cardinal Health (CAH) On A Strong Run With Fair Value Still In Focus"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 5,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.5,
            "source_article_count": 117,
            "discarded_article_count": 95
          },
          "sentimentPoints": 6
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 18.9,
        "grade": "一般",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 2.2,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 2.2,
            "vcp_reason": "波幅收縮(16.2%→5.6%)；跌縮量(近10日5日)；站上MA50；Ready=Y；Confirm=N",
            "vcp_metrics": {
              "up_days": 4,
              "vol_ref": 1875080,
              "down_days": 5,
              "vcp_ready": true,
              "above_ma50": true,
              "avg_vol_10": 1496960,
              "avg_vol_20": 1869665,
              "avg_vol_30": 1875080,
              "range_pct_10": 0.056261230926604684,
              "range_pct_20": 0.13050890802148143,
              "range_pct_30": 0.16166562952859934,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": false,
              "contraction_ok": true,
              "down_shrink_ok": true,
              "up_expand_days": 0,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.7983446039635642,
              "dist_to_20d_high": 0.09167631016942733,
              "down_shrink_days": 5,
              "breakout_level_20d": 258.29999,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.3480098465620476
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 2.4,
          "shortRsiPoints": 1,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 0.8
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.1280794476174236,
              "turnoverUsdM": 389.58205222000004,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.CAH",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 224.6342,
            "strength_details": {
              "ma_score": 2,
              "atr_score": 2,
              "rsi_score": 1,
              "macd_score": 1.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.2,
            "stop_loss_percent": 4.3,
            "take_profit_price": 246.351,
            "target_multiplier": 1.6,
            "technical_strength": 1.48,
            "take_profit_percent": 5
          },
          "positionPoints": 1.6,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 4.256158895234847,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 92.86,
    "atr": {
      "atr": 4.9929,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.13
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "弱勢",
      "score": 4,
      "value": -12.16
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.1438
    },
    "kdj": {
      "d": 49.91,
      "j": 62.78,
      "k": 54.2,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "弱流入",
      "score": 4,
      "value": 40.69
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 6,
      "trend": "有流入",
      "value": 20638881,
      "recentSlope": 147478.1,
      "previousSlope": 154590
    },
    "rsi": 41.83,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 237.7788,
      "position": "SAR喺價上",
      "distancePct": 1.35,
      "previousTrend": "下降"
    },
    "ma50": 233.0008,
    "macd": {
      "macd": 1.059068499902878,
      "trend": "中性偏多",
      "signal": 1.2252131912727,
      "histogram": -0.1661446913698219
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 235.8309,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "無力",
      "ratio": 0.9,
      "score": 4,
      "avgVolume": 1847969,
      "currentVolume": 1660481
    },
    "derived": {
      "ma20": 235.065,
      "ma50": 233.0008,
      "prevClose": 234.55,
      "avgVolume10": 1482818,
      "avgVolume20": 1847969,
      "changePercent": 0.03,
      "avgVolumeForScore": 1847969
    },
    "ma_cross": {
      "ma20": 235.065,
      "ma50": 233.0008,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "接近",
      "score": 6,
      "prevMa20": 235.114,
      "prevMa50": 232.7438,
      "spreadPct": 0.89,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 229.1156,
      "upper": 241.0144,
      "position": "中間"
    },
    "rsi_short": 69.95,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.9
    }
  }
}

{
  "close": 234.62,
  "volume": 1660481,
  "changePercent": 0.03
}